Cefiderocol Treatment for Severe Infections due to Difficult-to-Treat-Resistant Non-Fermentative Gram-Negative Bacilli in ICU Patients: A Case Series and Narrative Literature Review

Cefiderocol (FDC) is a siderophore cephalosporin now recognized as a new weapon in the treatment of difficult-to-treat-resistant (DTR) Gram-negative pathogens, including carbapenemase-producing enterobacterales and non-fermentative Gram-negative bacilli (GNB). This article reports our experience wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Wicky, Paul-Henri, Poiraud, Joséphine, Alves, Manuel, Patrier, Juliette, d’Humières, Camille, Lê, Minh, Kramer, Laura, de Montmollin, Étienne, Massias, Laurent, Armand-Lefèvre, Laurence, Timsit, Jean-François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295316/
https://www.ncbi.nlm.nih.gov/pubmed/37370310
http://dx.doi.org/10.3390/antibiotics12060991

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295316/
https://www.ncbi.nlm.nih.gov/pubmed/37370310
http://dx.doi.org/10.3390/antibiotics12060991

Ejemplares similares